Role of hematopoietic microenvironment in plexiform neurofibroma progression

造血微环境在丛状神经纤维瘤进展中的作用

基本信息

  • 批准号:
    8328651
  • 负责人:
  • 金额:
    $ 33.17万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-09-20 至
  • 项目状态:
    未结题

项目摘要

Plexiform neurofibromas are complex tumors characterized by tumorigenic Schwann cells, inflammatory cells, neoangiogenesis and alterations of the extracellular matrix. Our previous work provided genetic, cellular, and biochemical evidence that haploinsufficiency of Nfl alters Ras activity and cell fates in mast cells and that ckit activation of the hematopoietic system is required in the initiation of plexiform tumor formation in a murine model. In this application, we propose to build oh these observations to identify the underpinning mechanisms of how c-kit mediates its biological effects, and to identify experimental processes that would complement ckit mediated experimental therapeutics in the clinic. Three basic processes will be examined. First, kit activation is known to cooperate with integrin signals in enabling myeloid cells to adhere to blood vessel walls and emigrate from the blood to the emerging tumor. We have recently established that Nf 1 +/- mast cells preferentially adhere to alpha4beta1, an integrin that has a key role in mast cell adhesion to endothelium and in local sites of inflammation. We hypothesize that alpha4beta1 is crucial in the recruitment of Nf1+/- mast cells to the tumor microenvironment in promoting local mast cell proliferation and survival, and in the secretion of molecules that promote neoangiogenesis. We propose studies to test this hypothesis in vitro and in vivo. Second, MMPs are secreted molecules that promote the release of preformed growth factors to the circulation and degrade the extracellular matrix of tissues allowing invasion of inflammatory and stromal cells leading to tumor progression. In preliminary studies we detect one specific MMP that is preferentially expressed and activated. Studies to specifically test the role of this protease are proposed. Finally, the specific downstream paracrine signals that lead to alterations of the extracellular matrix and neoangiogenesis are incompletely understood. Tumor-associated macrophages are known to enhance neoangiogenesis and facilitate malignant outgrowth. We recently established that large populations of angiogenic macrophages are found in peripheral blood and in the neurofibromas of Krox20; Nfl flox/- mice. We hypothesize that macrophage recruitment and their role in neoangiogenesis is a key downstream event following mast cell recruitment to the tumor and, therefore, processes that inhibit this activity will prevent or delay tumor progression. Adoptive transfer experiments are proposed to test this hypothesis.
丛状神经纤维瘤是一种复杂的肿瘤,其特征是致瘤雪旺细胞、炎症细胞、新血管生成和细胞外基质的改变。我们之前的工作提供了遗传、细胞和生化证据,表明 Nfl 的单倍体不足会改变肥大细胞中的 Ras 活性和细胞命运,并且在小鼠模型中,造血系统的 ckit 激活是丛状肿瘤形成启动所必需的。在此应用中,我们建议建立这些观察结果,以确定 c-kit 如何介导其生物效应的基础机制,并确定补充临床中 ckit 介导的实验治疗的实验过程。将检查三个基本过程。首先,已知试剂盒激活与整合素信号配合,使骨髓细胞粘附在血管壁上并从血液迁移到新出现的肿瘤。我们最近确定 Nf 1 +/- 肥大细胞 优先粘附α4β1,这是一种整合素,在肥大细胞与内皮细胞的粘附中起关键作用, 在局部炎症部位。我们假设 alpha4beta1 在 Nf1+/- 肥大的招募中至关重要 细胞对肿瘤微环境的影响,促进局部肥大细胞增殖和存活,并在 分泌促进新血管生成的分子。我们提出研究来在体外和体内检验这一假设。其次,MMP 是一种分泌分子,可促进预先形成的生长因子释放到循环中并降解组织的细胞外基质,从而允许炎症和基质细胞侵入,导致肿瘤进展。在初步研究中,我们检测到一种优先表达和激活的特定 MMP。提出了专门测试这种蛋白酶作用的研究。最后,导致细胞外基质改变和新血管生成的特定下游旁分泌信号尚不完全清楚。已知肿瘤相关巨噬细胞可增强新血管生成并促进恶性生长。我们最近发现,在外周血和 Krox20 神经纤维瘤中发现了大量的血管生成巨噬细胞; Nfl flox/- 小鼠。我们假设巨噬细胞募集及其在新血管生成中的作用是肥大细胞募集到肿瘤后的关键下游事件,因此,抑制这种活性的过程将阻止或延缓肿瘤进展。提出过继转移实验来检验这一假设。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David W Clapp其他文献

David W Clapp的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David W Clapp', 18)}}的其他基金

TAM receptor inhibition in NF1-associated peripheral nerve sheath tumors
NF1 相关周围神经鞘肿瘤中的 TAM 受体抑制
  • 批准号:
    10741104
  • 财政年份:
    2023
  • 资助金额:
    $ 33.17万
  • 项目类别:
Preclinical-clinical trials collaboration to effectively advance new combination therapies for atypical neurofibroma in neurofibromatosis type 1
临床前-临床试验合作有效推进1型神经纤维瘤病非典型神经纤维瘤的新联合疗法
  • 批准号:
    10611130
  • 财政年份:
    2023
  • 资助金额:
    $ 33.17万
  • 项目类别:
Pediatric and Adult Translational Cancer Drug Discovery and Development Training Program (PACT-D3)
儿童和成人转化癌症药物发现和开发培训计划 (PACT-D3)
  • 批准号:
    10708526
  • 财政年份:
    2023
  • 资助金额:
    $ 33.17万
  • 项目类别:
Indiana Pediatric Scientist Award (IPSA)
印第安纳州儿科科学家奖 (IPSA)
  • 批准号:
    10598852
  • 财政年份:
    2023
  • 资助金额:
    $ 33.17万
  • 项目类别:
TAM receptor inhibition in NF1-associated peripheral nerve sheath tumors
NF1 相关周围神经鞘肿瘤中的 TAM 受体抑制
  • 批准号:
    10501263
  • 财政年份:
    2022
  • 资助金额:
    $ 33.17万
  • 项目类别:
TAM receptor inhibition in NF1-associated peripheral nerve sheath tumors
NF1 相关周围神经鞘肿瘤中的 TAM 受体抑制
  • 批准号:
    10913886
  • 财政年份:
    2022
  • 资助金额:
    $ 33.17万
  • 项目类别:
The Medical Physician Engineers, Scientists, and Clinicians Preparatory Program [MPESC-Prep]
医学医师工程师、科学家和临床医生预备计划 [MPESC-Prep]
  • 批准号:
    10618993
  • 财政年份:
    2022
  • 资助金额:
    $ 33.17万
  • 项目类别:
TAM receptor inhibition in NF1-associated peripheral nerve sheath tumors
NF1 相关周围神经鞘肿瘤中的 TAM 受体抑制
  • 批准号:
    10616770
  • 财政年份:
    2022
  • 资助金额:
    $ 33.17万
  • 项目类别:
Mitotic failure in Fanconi anemia: mechanisms and role in carcinogenesis
范可尼贫血的有丝分裂失败:机制和在致癌作用中的作用
  • 批准号:
    10001741
  • 财政年份:
    2020
  • 资助金额:
    $ 33.17万
  • 项目类别:
F-box ubiquitin ligases destabilize neurofibromin
F-box 泛素连接酶破坏神经纤维蛋白的稳定性
  • 批准号:
    9767890
  • 财政年份:
    2018
  • 资助金额:
    $ 33.17万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 33.17万
  • 项目类别:
    Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 33.17万
  • 项目类别:
    Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 33.17万
  • 项目类别:
    Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 33.17万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 33.17万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 33.17万
  • 项目类别:
    Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
  • 批准号:
    2230829
  • 财政年份:
    2023
  • 资助金额:
    $ 33.17万
  • 项目类别:
    Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 33.17万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 33.17万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 33.17万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了